TTLC 2022

Welcome Message

Dear Colleagues and Friends,  

The IASLC 2022 Targeted Therapies of Lung Cancer Meeting was originally scheduled to take place at the Fairmont Miramar in Santa Monica, California, USA.

However, due to the ongoing concerns caused by Coronavirus Disease (COVID-19) and the global surge in Omicron cases, the IASLC is transitioning the 2022 Targeted Therapies of Lung Cancer Meeting (TTLC22) to a fully virtual worldwide event from February 22-26, 2022. 

We are working on a virtual experience that will be both interesting and engaging. We are planning a robust agenda, with shorter days full of practice-changing science to accommodate more members’ schedules. 

This longstanding highly interactive meeting will feature novel research on emerging combination immunotherapy approaches and targets such as KRAS, G12C, and HER2. Relevant topics of effective therapeutic control of resistance to targeted therapies as well as the state of development of antibody-drug conjugates will be included in the program.    

We can’t wait to see you from February 22-26, 2022

TTLC 2022 Meeting Chairs

Paul A. Bunn, Jr.

Charu Aggarwal

Suresh Ramalingam

Lecia Sequist

Roy Herbst

TTLC 2022 Meeting Chairs

Healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians’ assistants.